Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TheraCal vs Calcium Hydroxide for Indirect Pulp Treatment in Primary Molars
NCT03791255Phase 4Unknown
- Sponsor
- Cairo University
- Start
- Feb 2019
- Primary completion
- Feb 2020
01
Overview
Phase 4, randomised trial (2 arms), sponsored by Cairo University. Primary endpoint: Postoperative pain at 12 months. Status: unknown.
Beyond the preview
Go deeper on NCT03791255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03791255.